Filters

Filters
See more See less

Showing 21–40 of 725 results

Cryovial of Alopecia PBMC - Sanguine Biosciences, Inc

Alopecia PBMC

Alopecia PBMC samples are isolated from donors with clinically confirmed alopecia, including alopecia areata. Ideal for studying autoreactive T cells, immune cell signaling, and hair follicle–targeted autoimmunity.

Cryovial of Alopecia Plasma - Sanguine Biosciences, Inc

Alopecia Plasma

Alopecia Plasma is collected from donors with clinically confirmed alopecia. Useful for analyzing circulating cytokines, inflammatory markers, and immune modulators involved in hair loss.

Cryovial of Alopecia Serum - Sanguine Biosciences, Inc

Alopecia Serum

Alopecia Serum is collected from donors with clinically confirmed alopecia. Ideal for detecting autoantibodies, cytokines, and other biomarkers of autoimmune and inflammatory skin disorders.

Alopecia Whole Blood - Sanguine Biosciences, Inc

Alopecia Whole Blood

Alopecia Whole Blood is collected from donors with clinically confirmed alopecia. Suitable for transcriptomic studies, immune profiling, and genetic research in autoimmune hair loss conditions.

Alpha-gal syndrome AGS Leukopak Collection - Sanguine Biosciences Inc.

Alpha-Gal Syndrome Leukopak

LeukoCore™ Alpha-Gal Syndrome Leukopak products contain concentrated immune cells from donors with clinically confirmed alpha-gal syndrome (AGS), collected via apheresis. Ideal for high-yield studies on AGS-related inflammation, cytokine signaling, and immune cell profiling.

Cryovial of Alpha-Gal Syndrome PBMC - Sanguine Biosciences Inc.

Alpha-Gal Syndrome PBMC

Alpha-Gal Syndrome PBMC samples are collected from clinically confirmed Alpha-Gal Syndrome donors and cryopreserved for downstream immunology and inflammatory research. Ideal for studying inflammatory pathways, immune cell responses, and therapeutic development in Alpha-Gal Syndrome.

Cryovial of Alpha-gal syndrome plasma - Sanguine Biosciences

Alpha-Gal Syndrome Plasma

Alpha-Gal Syndrome Plasma – Cryopreserved human plasma collected from clinically confirmed alpha-gal syndrome (AGS) donors. Alpha-Gal Syndrome plasma is ideal for inflammation studies, cytokine profiling, and inflammatory focused biomarker research.

Cryovial of Alpha-gal syndrome serum - Sanguine Biosciences

Alpha-Gal Syndrome Serum

Alpha-Gal Syndrome Serum – Human serum samples collected from clinically confirmed alpha-gal syndrome (AGS) donors. Ideal for inflammatory studies, cytokine profiling, and inflammation-related research.

Alpha-Gal Syndrome Whole Blood

Alpha-Gal Syndrome Whole Blood

Fresh Alpha-Gal Syndrome Whole Blood – IRB-consented alpha-gal syndrome whole blood samples collected from donors diagnosed with alpha-gal syndrome (AGS). Ideal for dermatology, immunology, and inflammation-based research.

Cryovial of ALSP PBMC Blood Sample - Sanguine Biosciences, Inc.

ALSP PBMC

ALSP PBMC samples are collected from clinically confirmed adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) donors and cryopreserved for downstream neurological research. Ideal for studying neuroinflammation, genetic mutations, and potential ALSP therapies.

Cryovial of ALSP Plasma - Sanguine Biosciences

ALSP Plasma

ALSP Plasma – Cryopreserved human plasma collected from clinically confirmed adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) donors. ALSP plasma is ideal for inflammation studies, cytokine profiling, and neuro-focused biomarker research.

Cryovial of ALSP serum - Sanguine Biosciences

ALSP Serum

ALSP Serum – Human ALSP serum samples collected from clinically confirmed adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) donors. Ideal for dermatology, cytokine profiling, and inflammation-related research.

ALSP Whole Blood

ALSP Whole Blood

Fresh ALSP Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Ideal for dermatology, immunology, and inflammation-based research.

Cryovial of Alzheimer's Disease PBMC - Sanguine Biosciences

Alzheimer’s Disease PBMC

Alzheimer’s Disease PBMC samples are collected from clinically confirmed Alzheimer’s Disease donors and cryopreserved for downstream neurological research. Ideal for studying pathogenesis, biomarkers, and therapeutic development in Alzheimer’s Disease.

Cryovial of Alzheimer's Disease Plasma - Sanguine Biosciences

Alzheimer’s Disease Plasma

Alzheimer’s Disease Plasma – Cryopreserved human Alzheimer’s Disease plasma collected from clinically confirmed Alzheimer’s Disease donors. Alzheimer’s Disease plasma is ideal for biomarker identification and the development of therapeutic treatments.

Cryovial of Alzheimer's Disease serum - Sanguine Biosciences

Alzheimer’s Disease Serum

Alzheimer’s Disease Serum – Human Alzheimer’s Disease serum samples collected from clinically confirmed Alzheimer’s Disease donors. Ideal for neurological research.

Alzheimer’s Disease Whole Blood

Alzheimer’s Disease Whole Blood

Alzheimer’s Disease Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Alzheimer’s Disease. Ideal for biomarker identification and diagnostic and therapeutic development in Alzheimer’s Disease.

Cryovial of Amyloidosis PBMC - Sanguine Biosciences, Inc

Amyloidosis PBMC

Amyloidosis PBMC samples are isolated from donors with clinically confirmed amyloidosis. Ideal for studying immune system involvement, plasma cell dysregulation, and cellular responses to amyloid protein deposition.

Cryovial of Amyloidosis Plasma - Sanguine Biosciences, Inc

Amyloidosis Plasma

Amyloidosis Plasma is collected from donors with clinically confirmed amyloidosis. Useful for analyzing circulating amyloid precursors, inflammatory cytokines, and biomarkers of systemic protein misfolding.

Cryovial of Amyloidosis Serum - Sanguine Biosciences, Inc

Amyloidosis Serum

Amyloidosis Serum is collected from donors with clinically confirmed amyloidosis. Ideal for detecting light chains, amyloid-associated proteins, and tracking disease progression in systemic amyloidosis.